Skip to main content

Jackson Financial Inc.

For the period ended Mar 31, 2026. Filed May 5, 2026.

View on SEC.gov

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Mar 31, 2026 · Filed May 5, 2026

JXN$131.69-0.8%Stored close · as of Nov 6, 2026
See the whole filing, with its images and exhibits

Condensed Consolidated Balance Sheet

Condensed Consolidated Balance Sheets

(in millions, except share data)

March 31,December 31,
20262025
Assets · (Unaudited)
Investments:
Debt Securities, available-for-sale, net of allowance for credit losses of $17 and $11 at March 31, 2026 and December 31, 2025, respectively (amortized cost: 2026 $52,356; 2025 $50,491)$48,597$47,321
Debt Securities, at fair value under fair value option3,3513,470
Equity securities, at fair value243172
Mortgage loans, net of allowance for credit losses of $159 and $133 at March 31, 2026 and December 31, 2025, respectively10,2489,887
Mortgage loans, at fair value under fair value option196324
Policy loans (including $3,556 and $3,537 at fair value under the fair value option at March 31, 2026 and December 31, 2025, respectively)4,4314,426
Freestanding derivative instruments701448
Other invested assets3,2463,185
Total investments71,01369,233
Cash and cash equivalents5,5395,704
Accrued investment income636634
Deferred acquisition costs11,63411,660
Reinsurance recoverable, net of allowance for credit losses of $30 and $30 at March 31, 2026 and December 31, 2025, respectively18,92619,518
Reinsurance recoverable on market risk benefits, at fair value121118
Market risk benefit assets, at fair value6,7017,867
Deferred income taxes, net610719
Other assets905637
Separate account assets223,452236,496
Total assets$339,537$352,586
Liabilities and Equity
Liabilities
Reserves for future policy benefits and claims payable$10,706$10,896
Other contract holder funds68,70367,663
Market risk benefit liabilities, at fair value3,9713,754
Funds withheld payable under reinsurance treaties (including $3,744 and $3,723 at fair value under the fair value option at March 31, 2026 and December 31, 2025, respectively)14,51114,960
Long-term debt2,0272,030
Repurchase agreements and securities lending payable5051,036
Collateral payable for derivative instruments34358
Freestanding derivative instruments238257
Notes issued by consolidated variable interest entities, at fair value under fair value option (see Note 4)2,5432,578
Other liabilities2,6382,516
Separate account liabilities223,452236,496
Total liabilities329,637342,244
Commitments, Contingencies, and Guarantees (see Note 16)
Equity
Series A non-cumulative preferred stock and additional paid in capital, $1.00 par value per share: 24,000 shares authorized; 22,000 shares issued and outstanding at March 31, 2026 and December 31, 2025; liquidation preference $25,000 per share (see Note 19)533533
Common stock; 1,000,000,000 shares authorized, $0.01 par value per share and 70,270,752 and 66,825,632 shares issued and outstanding at March 31, 2026 and December 31, 2025, respectively (see Note 19)11
Additional paid-in capital6,3936,063
Treasury stock, at cost; 24,217,563 and 27,662,683 shares at March 31, 2026 and December 31, 2025, respectively(1,671)(1,645)
Accumulated other comprehensive income (loss), net of tax expense (benefit) of $(287) and $(377) at March 31, 2026 and December 31, 2025, respectively(2,728)(2,470)
Retained earnings6,9687,471
Total shareholders' equity9,4969,953
Noncontrolling interests404389
Total equity9,90010,342
Total liabilities and equity$339,537$352,586
ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.